| Authors: |
Sheikh A; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom., Achten A; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands., Aimo A; Health Sciences Interdisciplinary Center, Scuola Superiore Sant'Anna, Pisa, Italy; Cardiology Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy., Razvi Y; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom., Mansell J; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom., Rauf MU; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom., Porcari A; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom; Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart, Trieste, Italy., Patel R; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom., Venneri L; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom., Martinez-Naharro A; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom., Whelan C; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom., Quarta C; Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, USA., Virsinskaite R; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom., Feffer Barak D; Humanitas University, Milan, Italy., Wechalekar A; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom., Lachmann H; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom., Knight D; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom; UCL Institute of Cardiovascular Science, University College London, Gower Street, London, United Kingdom., Kotecha T; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom., Kellman P; National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA., Manisty C; Barts Heart Centre, London, United Kingdom., Moon J; Barts Heart Centre, London, United Kingdom., Emdin M; Health Sciences Interdisciplinary Center, Scuola Superiore Sant'Anna, Pisa, Italy; Cardiology Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy., Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Hawkins PN; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom., Gillmore J; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom., Fontana M; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom. Electronic address: m.fontana@ucl.ac.uk. |
